March 11, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to ...

Dianthus Therapeutics ( NASDAQ:DNTH ) Full Year 2024 Results Key Financial Results Net loss: US$85.0m (loss widened by... Phase 2 MaGic trial of DNTH103 in generalized Myasthenia Gravis (gMG ...

One of the most iconic yellow flowers in India is the Marigold (Tagetes erecta). Marigolds are commonly used for decorative garlands and offerings, and they brighten up homes during festivals like ...

Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies.